ZA200609967B - Treating respiratory diseases with glycopyrrolate and analogues - Google Patents

Treating respiratory diseases with glycopyrrolate and analogues

Info

Publication number
ZA200609967B
ZA200609967B ZA200609967A ZA200609967A ZA200609967B ZA 200609967 B ZA200609967 B ZA 200609967B ZA 200609967 A ZA200609967 A ZA 200609967A ZA 200609967 A ZA200609967 A ZA 200609967A ZA 200609967 B ZA200609967 B ZA 200609967B
Authority
ZA
South Africa
Prior art keywords
glycopyrrolate
analogues
respiratory diseases
treating respiratory
treating
Prior art date
Application number
ZA200609967A
Other languages
English (en)
Inventor
Snape Susan
Bannister Robin Mark
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of ZA200609967B publication Critical patent/ZA200609967B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200609967A 2004-05-10 2005-05-10 Treating respiratory diseases with glycopyrrolate and analogues ZA200609967B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0410398.2A GB0410398D0 (en) 2004-05-10 2004-05-10 The treatment of respiratory disease

Publications (1)

Publication Number Publication Date
ZA200609967B true ZA200609967B (en) 2008-06-25

Family

ID=32526759

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200609967A ZA200609967B (en) 2004-05-10 2005-05-10 Treating respiratory diseases with glycopyrrolate and analogues

Country Status (14)

Country Link
US (1) US20080020048A1 (ja)
EP (1) EP1750806A2 (ja)
JP (1) JP2007536361A (ja)
CN (1) CN1950127A (ja)
AU (1) AU2005240404B2 (ja)
BR (1) BRPI0510947A (ja)
CA (1) CA2566339A1 (ja)
GB (1) GB0410398D0 (ja)
IL (1) IL178815A (ja)
MX (1) MXPA06013039A (ja)
NO (1) NO20065535L (ja)
NZ (1) NZ550911A (ja)
WO (1) WO2005107872A2 (ja)
ZA (1) ZA200609967B (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
GB0523654D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0523656D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
AU2013205983A1 (en) * 2008-02-26 2013-06-13 Sunovion Respiratory Development Inc. Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
EP3311820A1 (en) * 2008-02-26 2018-04-25 Sunovion Respiratory Development Inc. Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
US20100055045A1 (en) 2008-02-26 2010-03-04 William Gerhart Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations
US8580801B2 (en) * 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
JO3510B1 (ar) * 2011-03-04 2020-07-05 Heptares Therapeutics Ltd استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
EP2826479B1 (en) * 2012-03-14 2019-02-20 LTT Bio-Pharma Co., Ltd. Ameliorating agent for chronic obstructive pulmonary disease
WO2014062143A2 (en) * 2012-10-19 2014-04-24 Mahmut Bilgic Anticholinergic agent combinations
WO2014077787A1 (en) * 2012-11-16 2014-05-22 Mahmut Bilgic Combinations including abeta2 agonist and glycopyrrolate
AU2013368298B2 (en) * 2012-12-27 2016-08-11 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
TWI602566B (zh) 2014-09-09 2017-10-21 維克杜拉有限公司 調配物、方法及裝置
US9968125B2 (en) 2015-01-09 2018-05-15 Philip Morris Products S.A. Nicotine—diketopiperazine microparticle formulations and methods of making the same
US11224594B2 (en) 2015-09-16 2022-01-18 Philip Morris Products S.A. Nicotine formulations and methods of making and using the same
US10149844B2 (en) 2015-09-16 2018-12-11 Philip Morris Products S.A. Inhalable nicotine formulations, and methods of making and using thereof
US20170071248A1 (en) 2015-09-16 2017-03-16 Sansa Corporation (Barbados) Inc. System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations
US9585835B1 (en) 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645466B1 (en) * 1998-11-13 2003-11-11 Jago Research Ag Dry powder for inhalation
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
RU2438660C2 (ru) * 2004-02-06 2012-01-10 Меда Фарма Гмбх Унд Ко. Кг Комбинация и фармацевтический препарат для лечения воспалительных и обструктивных заболеваний дыхательных путей
GB0410399D0 (en) * 2004-05-10 2004-06-16 Arakis Ltd The treatment of respiratory disease

Also Published As

Publication number Publication date
WO2005107872A3 (en) 2006-03-16
AU2005240404B2 (en) 2009-04-23
AU2005240404A1 (en) 2005-11-17
CA2566339A1 (en) 2005-11-17
IL178815A (en) 2011-10-31
GB0410398D0 (en) 2004-06-16
IL178815A0 (en) 2007-05-15
JP2007536361A (ja) 2007-12-13
BRPI0510947A (pt) 2007-11-20
US20080020048A1 (en) 2008-01-24
CN1950127A (zh) 2007-04-18
NZ550911A (en) 2010-10-29
MXPA06013039A (es) 2007-06-19
WO2005107872A2 (en) 2005-11-17
NO20065535L (no) 2006-12-08
EP1750806A2 (en) 2007-02-14

Similar Documents

Publication Publication Date Title
ZA200609967B (en) Treating respiratory diseases with glycopyrrolate and analogues
PL2689767T3 (pl) Kompozycje i sposoby ich stosowania do poprawy stanu i wyglądu skóry
IL188420A0 (en) Methods and compositions with enhanced therapeutic activity
PL3542869T3 (pl) Jednorazowy monitor snu i oddechu
ZA200802415B (en) Method and means of preventing and treating sleep disordered breathing
HK1103370A1 (en) Respiratory devices and methods of use
EP1742640A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF ILLNESSES AND SUFFERING IN CONNECTION WITH THE MITOCHONDRY FUNCTION
EP1737482A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
PT1711070E (pt) Composição nutricional para melhorar o estado da pele e prevenir doenças de pele
ZA200701820B (en) Substituted phenylaminothiazoles and use thereof
IL177845A0 (en) Combination therapy with glatiramer acetate and riluzole
GB0410399D0 (en) The treatment of respiratory disease
PL2215908T3 (pl) 2-alkilo-cykloalk(en)ylo-karboksamidy i ich zastosowanie jako fungicydów
GB0428170D0 (en) Mono and Combination Therapy
EP1601348A4 (en) Compositions and methods with improved therapeutic activity
HK1097495A1 (en) Can body and can
GB0407382D0 (en) Therapeutic methods and means
IL185575A0 (en) Benzoxazocines and their therapeutic use
GB0701549D0 (en) Skin treatment
EP1778228A4 (en) THERAPEUTIC CONNECTION AND TREATMENTS
GB0426141D0 (en) Treatment
GB0425854D0 (en) Therapeutic treatment
GB0421731D0 (en) Respiratory monitor
GB0408752D0 (en) Therapeutic treatment
GB0512551D0 (en) Methods and therapeutic treatments